913
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Docking, CoMFA and CoMSIA studies of a series of sulfonamides derivatives as carbonic anhydrase I inhibitors

&
Pages 320-327 | Received 26 Jul 2011, Accepted 14 Sep 2011, Published online: 06 Dec 2011

References

  • Keilin D, Mann T. Carbonic anhydrase. Purification and nature of the enzyme. Biochem J 1940;34:1163–1176.
  • Nuti E, Orlandini E, Nencetti S, Rossello A, Innocenti A, Scozzafava A et al. Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates. Bioorg Med Chem 2007;15:2298–2311.
  • Clare BW, Supuran CT. A physically interpretable quantum-theoretic QSAR for some carbonic anhydrase inhibitors with diverse aromatic rings, obtained by a new QSAR procedure. Bioorg Med Chem 2005;13:2197–2211.
  • Gavernet L, Gonzalez Funes JL, Blanch LB, Estiu G, Maresca A, Supuran CT. Affinity of sulfamates and sulfamides to carbonic anhydrase II isoform: experimental and molecular modeling approaches. J Chem Inf Model 2010;50:1113–1122.
  • Tarko L, Supuran CT. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides. Bioorg Med Chem 2007;15:5666–5671.
  • Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
  • Supuran CT, Winum JY (ed.: Wang B). Wiley, Hoboken, NJ, 2009, p. 19.
  • Yoshida T, Munei Y, Hitaoka S, Chuman H. Correlation analyses on binding affinity of substituted benzenesulfonamides with carbonic anhydrase using ab initio MO calculations on their complex structures. J Chem Inf Model 2010;50:850–860.
  • Pastorekova S, Parkkila S, Zavada J. Tumor-associated carbonic anhydrases and their clinical significance. Adv Clin Chem 2006;42:167–216.
  • Zhang L, Tsai KC, Du L, Fang H, Li M, Xu W. How to generate reliable and predictive CoMFA models. Curr Med Chem 2011;18:923–930.
  • Abdel-Hamid MK, Abdel-Hafez AA, El-Koussi NA, Mahfouz NM, Innocenti A, Supuran CT. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity. Bioorg Med Chem 2007;15:6975–6984.
  • Agrawal VK, Banerji M, Gupta M, Singh J, Khadikar PV, Supuran CT. QSAR study on carbonic anhydrase inhibitors: water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long lasting-intra ocular pressure lowering properties–a molecular connectivity approach. Eur J Med Chem 2005;40:1002–1012.
  • Agrawal VK, Bano S, Supuran CT, Khadikar PV. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents. Eur J Med Chem 2004;39:593–600.
  • Melagraki G, Afantitis A, Sarimveis H, Igglessi-Markopoulou O, Supuran CT. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices. Bioorg Med Chem 2006;14:1108–1114.
  • Vicker N, Ho Y, Robinson J, Woo LL, Purohit A, Reed MJ et al. Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II. Bioorg Med Chem Lett 2003;13:863–865.
  • Clare BW, Supuran CT. Carbonic anhydrase inhibitors. Part 86. A QSAR study on some sulfonamide drugs which lower intra-ocular pressure, using the ACE non-linear statistical method. Eur J Med Chem 2000;35:859–865.
  • Supuran CT, Clare BW. Carbonic anhydrase inhibitors − Part 57: Quantum chemical QSAR of a group of 1,3,4-thiadiazole- and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties. Eur J Med Chem 1999;34:41–50.
  • Güzel O, Maresca A, Hall RA, Scozzafava A, Mastrolorenzo A, Mühlschlegel FA et al. Carbonic anhydrase inhibitors. The beta-carbonic anhydrases from the fungal pathogens Cryptococcus neoformans and Candida albicans are strongly inhibited by substituted-phenyl-1H-indole-5-sulfonamides. Bioorg Med Chem Lett 2010;20:2508–2511.
  • Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988;110:5959–5967.
  • Klebe G, Abraham U, Mietzner T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 1994;37:4130–4146.
  • Pirhadi S, Ghasemi JB. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA. Eur J Med Chem 2010;45:4897–4903.
  • Momany FA, Rone R. Validation of the general purpose QUANTA ®3.2/CHARMm® force field. J Comput Chem 1992;13:888–900.
  • Discovery Studio, Accelrys Software, Inc, San Diego, CA, 2009.
  • Politi A, Durdagi S, Moutevelis-Minakakis P, Kokotos G, Mavromoustakos T. Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies. J Mol Graph Model 2010;29:425–435.
  • GOLD: User Guides and Tutorials http://www.ccdc.cam.ac.uk/support/documentation/gold/3_1/gold31.pdf (2006).
  • Tripos, QSARTM Manual, SYBYL, version 7.3, 2006, St. Louis 2006.
  • Baroni M, Costantino G, Cruciani G, Riganelli D, Valigi R, Clementi S. Generating Optimal Linear PLS Estimations (GOLPE): An advanced chemometric tool for handling 3D-QSAR problems. Quant Struct Act Relat 1993;12:9–20.
  • Cho SJ, Tropsha A. Cross-validated R2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results. J Med Chem 1995;38:1060–1066.
  • Wang R, Gao Y, Liu L, Lai L. All-orientation search and all-placement search in comparative molecular field analysis. J Mol Model 1998;4:276–283.
  • Clark R, Fox P. Statistical variation in progressive scrambling. J Comput Aided Mol Des 2004;18:563–576.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.